PROJECT GOLD
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98160589
- Registration number
- 7584273
- Mark type
- Stylized text
- Filed
- 01 Sept 2023
- Published for opposition
- 10 Sept 2024
- Registered
- 03 Dec 2024
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 035 — Advertising and business services: Promoting the interests of cancer patients by means of public advocacy, specifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review services, namely, generic drugs for cancer treatment; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry, namely, the manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticals, namely, generic drugs for cancer treatment
- Class 040 — Treatment of materials: Consulting services in the field of pharmaceutical manufacturing, namely, generic drugs for cancer treatment
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical advice, namely, to facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, namely, generic drugs for cancer treatment
- Class 045 — Legal and security services: Providing patient advocate services in the field of cancer treatment, namely, increasing access to and availability of generic drugs therefor; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication, specifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programs, namely, for access to and availability of generic drugs for cancer treatment
Owner
- Curae Pharma360, Inc., San Francisco, CA, US
- Curae Pharma360, Inc., San Francisco, CA, US
- Curae Pharma360, Inc., San Francisco, CA, US
- Angels for Change Inc., Valrico, FL, US
- Angels for Change Inc., Valrico, FL, US
- Angels for Change Inc., Valrico, FL, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 06 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 06 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 05 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 May 2024 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 03 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED